Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10. Clinical Medicine and Pharmacology, [S. l.], v. 2, n. 1, p. 1–7, 2025. DOI: 10.70731/rek12e38. Disponível em: https://jandoopress.com/journal/cmp/article/view/73. Acesso em: 24 jun. 2026.